Christina York
Principal investigator, leads ALTALITY, INC. and ALTality, LLC.
Digital healthFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$3.3MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $3.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Feb 14, 2023 | NIH | SBIR Phase I Feasibility of a dual English/Spanish mobile augmented reality pain assessment app to reduce postoperative prescription opioid use in Hispanic/Latino pediatric and adolescent cancer patients | $55K | ALTality, LLC |
| Feb 14, 2023 | NIH | SBIR Phase I Feasibility of a dual English/Spanish mobile augmented reality pain assessment app to reduce postoperative prescription opioid use in Hispanic/Latino pediatric and adolescent cancer patients | $55K | ALTALITY, INC. |
| Sep 22, 2022 | NIH | SBIR Phase I Feasibility of a dual English/Spanish mobile augmented reality pain assessment app to reduce postoperative prescription opioid use in Hispanic/Latino pediatric and adolescent cancer patients | $256K | ALTality, LLC |
| Sep 22, 2022 | NIH | SBIR Phase I Feasibility of a dual English/Spanish mobile augmented reality pain assessment app to reduce postoperative prescription opioid use in Hispanic/Latino pediatric and adolescent cancer patients | $256K | ALTALITY, INC. |
| Aug 24, 2022 | NIH | STTR Phase II An augmented reality platform to reduce post-operative and chronic opioid use in pediatric cancer | $913K | ALTality, LLC |
| Aug 24, 2022 | NIH | STTR Phase II An augmented reality platform to reduce post-operative and chronic opioid use in pediatric cancer | $913K | ALTALITY, INC. |
| Sep 1, 2021 | NIH | STTR Phase II An augmented reality platform to reduce post-operative and chronic opioid use in pediatric cancer | $1.8M | ALTality, LLC with UNIVERSITY OF TX MD ANDERSON CAN CTR |
| Sep 1, 2021 | NIH | STTR Phase II An augmented reality platform to reduce post-operative and chronic opioid use in pediatric cancer | $1.8M | ALTALITY, INC. with UNIVERSITY OF TX MD ANDERSON CAN CTR |
| May 29, 2020 | NIH | STTR Phase II An augmented reality platform to reduce post-operative and chronic opioid use in pediatric cancer | $279K | ALTality, LLC |
| May 29, 2020 | NIH | STTR Phase II An augmented reality platform to reduce post-operative and chronic opioid use in pediatric cancer | $279K | ALTALITY, INC. |
Peer ranks
Federal funding#82
Awards as PI#83
Patents#45
Companies
- ALTALITY, INC.Leads (SEC Form D) · Digital health
- ALTality, LLCLeads (SEC Form D)
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.